Mary Smith's most recent trade in KAR Auction Services Inc was a trade of 946 Common Stock done at an average price of $24.5 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 24.45 per share. | 30 Jun 2025 | 946 | 36,724 (0%) | 0% | 24.5 | 23,130 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 7,195 | 43,323 | - | - | Phantom Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 19.28 per share. | 31 Mar 2025 | 1,200 | 35,778 (0%) | 0% | 19.3 | 23,136 | Common Stock |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 17,813 (0%) | 0% | 0 | Common Stock | |
| KAR Auction Services Inc | Smith Ellen Mary | Director | Grant, award, or other acquisition of securities at price $ 19.84 per share. | 31 Dec 2024 | 1,166 | 34,578 (0%) | 0% | 19.8 | 23,133 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 16.88 per share. | 30 Sep 2024 | 1,370 | 33,412 (0%) | 0% | 16.9 | 23,126 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 16.59 per share. | 30 Jun 2024 | 1,394 | 32,042 (0%) | 0% | 16.6 | 23,126 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 10,132 | 36,128 | - | - | Phantom Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 31 Mar 2024 | 1,337 | 30,648 (0%) | 0% | 17.3 | 23,130 | Common Stock |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 13,813 (0%) | 0% | 0 | Common Stock | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 21,156 | 239,095 (0%) | 0% | 0 | Common Stock | |
| SpringWorks Therapeutics Inc | Smith L. Mary | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.53 per share. | 04 Jan 2024 | 3,535 | 233,363 (0%) | 0% | 41.5 | 146,809 | Common Stock |
| SpringWorks Therapeutics Inc | Smith L. Mary | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.96 per share. | 04 Jan 2024 | 2,197 | 236,898 (0%) | 0% | 38.0 | 83,398 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 5,720 | 217,939 (0%) | 0% | - | Common Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 11,032 | 25,996 | - | - | Phantom Stock | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.41 per share. | 07 Jan 2023 | 1,068 | 212,219 (0%) | 0% | 26.4 | 28,206 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 22,663 | 215,739 (0%) | 0% | - | Common Stock | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 9,813 (0%) | 0% | 0 | Common Stock | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.52 per share. | 05 Jan 2023 | 2,452 | 213,287 (0%) | 0% | 27.5 | 67,479 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 13.05 per share. | 31 Dec 2022 | 1,773 | 29,311 (0%) | 0% | 13.1 | 23,138 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 11.17 per share. | 30 Sep 2022 | 2,071 | 27,538 (0%) | 0% | 11.2 | 23,133 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.47 per share. | 18 Jul 2022 | 1,551 | 193,076 (0%) | 0% | 28.5 | 44,157 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 6,092 | 194,627 (0%) | 0% | 0 | Common Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 14.77 per share. | 30 Jun 2022 | 1,566 | 25,467 (0%) | 0% | 14.8 | 23,130 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 7,832 | 14,964 | - | - | Phantom Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 18.05 per share. | 31 Mar 2022 | 1,282 | 23,901 (0%) | 0% | 18.0 | 23,140 | Common Stock |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 5,813 (0%) | 0% | 0 | Common Stock | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.06 per share. | 07 Jan 2022 | 1,181 | 188,535 (0%) | 0% | 56.1 | 66,207 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 69,207 | 69,207 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 22,205 | 189,716 (0%) | 0% | - | Common Stock | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 13 Oct 2021 | 10,000 | 177,511 (0%) | 0% | 2.3 | 23,000 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2021 | 10,000 | 84,296 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 55.97 per share. | 13 Oct 2021 | 10,000 | 167,511 (0%) | 0% | 56.0 | 559,675 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 16.39 per share. | 30 Sep 2021 | 1,411 | 21,138 (0%) | 0% | 16.4 | 23,126 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 13 Jul 2021 | 10,000 | 177,511 (0%) | 0% | 2.3 | 23,000 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 10,000 | 94,296 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 80.88 per share. | 13 Jul 2021 | 10,000 | 167,511 (0%) | 0% | 80.9 | 808,777 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 17.55 per share. | 30 Jun 2021 | 1,243 | 19,727 (0%) | 0% | 17.6 | 21,815 | Common Stock |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 5,834 | 5,834 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 1,650 | 1,650 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 963 | 2,613 (0%) | 0% | 0 | Common Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 7,132 | 7,132 | - | - | Phantom Stock | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 13 Apr 2021 | 10,000 | 177,511 (0%) | 0% | 2.3 | 23,000 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 10,000 | 104,296 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 68.07 per share. | 13 Apr 2021 | 10,000 | 167,511 (0%) | 0% | 68.1 | 680,723 | Common Stock |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Grant, award, or other acquisition of securities at price $ 15.00 per share. | 31 Mar 2021 | 1,417 | 18,484 (0%) | 0% | 15 | 21,255 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 78.70 per share. | 20 Jan 2021 | 10,000 | 167,511 (0%) | 0% | 78.7 | 787,016 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 20 Jan 2021 | 8,872 | 177,511 (0%) | 0% | 2.3 | 20,406 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 8,872 | 114,296 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 1,128 | 1,451 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.65 per share. | 20 Jan 2021 | 1,128 | 168,639 (0%) | 0% | 1.6 | 1,861 | Common Stock |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | L. Mary Smith | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 11,000 | 167,511 (0%) | 0% | 0 | Common Stock | |
| KAR Auction Services Inc | Mary Ellen Smith | Director | Purchase of securities on an exchange or from another person at price $ 17.78 per share. | 11 Nov 2020 | 5,000 | 17,067 (0%) | 0% | 17.8 | 88,900 | Common Stock |